Reuters Health Summit -- May 9-12 -- FDA Official and Leading CEOs From Health Corporations to Discuss the Outlook for Healthcare

Americans. And in the midst of these strategic changes, the medical community still awaits exciting new therapies for multiple sclerosis, hepatitis C and cancer from these corporate laboratories. Some of the healthcare industry's most prominent...